-
-
-
-
-
-
-
MBX Biosciences receives FDA feedback for phase 3 hypoparathyroidism trial
-
-
-
-
-
-
-
Microbix Reports Results for Q4 and Fiscal 2025
-
-
-
-
-
-
-
MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
-
-
-
-
-
-
-
Microbix Reports Results for Q3 Fiscal 2025
-
-
-
-
-
-
-
Microbix Reports Results for Q2 Fiscal 2025
-
-
-
-
-
-
-
Microbix Exhibiting at ESCMID Global 2025
-
-
-
-
-
-
-
Microbix Hosts Ontario Premier Doug Ford & Team
-
1,199,634 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

